Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Endocrine function in multiple sclerosis.

P Klapps1, S Seyfert, T Fischer

  • 1Neurology Clinic, Steglitz Clinic, Free University of Berlin, Germany.

Acta Neurologica Scandinavica
|May 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cedalion Tutorial: A Python-based framework for comprehensive analysis of multimodal fNIRS & DOT from the lab to the everyday world.

ArXiv·2026
Same author

Early image acquisition <sup>68</sup>Ga-FAPI-46-PET/CT in prone position is promising in the workup of rectosigmoid and anal carcinoma.

European journal of nuclear medicine and molecular imaging·2025
Same author

Development of a breathing lung phantom for proton CT imaging.

Physics in medicine and biology·2025
Same author

[Fulminant amniotic fluid embolism with subsequent cesarean section under prolonged resuscitation-A case report].

Die Anaesthesiologie·2024
Same author

Prevention of legionella infections from toilet flushing cisterns.

The Journal of hospital infection·2024
Same author

The relevance of reducing Veress needle overshooting.

Scientific reports·2023
Same journal

Editorial.

Acta neurologica Scandinavica·2022
Same journal

Advances in sudden unexpected death in epilepsy.

Acta neurologica Scandinavica·2022
Same journal

Non-convulsive seizures and non-convulsive status epilepticus in neuro-intensive care unit.

Acta neurologica Scandinavica·2022
Same journal

Positron emission tomography in autoimmune encephalitis: Clinical implications and future directions.

Acta neurologica Scandinavica·2022
Same journal

Seizure detection based on wearable devices: A review of device, mechanism, and algorithm.

Acta neurologica Scandinavica·2022
Same journal

Walking confidence and perceived locomotion ability explain participation after stroke: A cross-sectional experimental study.

Acta neurologica Scandinavica·2022
See all related articles

This study assessed endocrine function in multiple sclerosis (MS) patients. While overt endocrine diseases were rare, some patients showed impaired hormone secretion, suggesting potential preclinical endocrine insufficiency.

Area of Science:

  • Endocrinology
  • Neurology
  • Multiple Sclerosis Research

Background:

  • Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
  • Endocrine dysfunction can occur in MS, impacting patient quality of life.
  • The interplay between MS and the endocrine system requires further investigation.

Purpose of the Study:

  • To evaluate the endocrine functions of the hypothalamus, pituitary, and peripheral glands in patients with MS.
  • To identify the prevalence of overt endocrine diseases in this population.
  • To explore potential preclinical endocrine insufficiencies.

Main Methods:

  • A cohort of 31 patients with multiple sclerosis (MS) underwent a combined pituitary function test.
  • Hormone levels (cortisol, growth hormone, thyroid-stimulating hormone) were assessed post-stimulation.

Related Experiment Videos

  • Clinical assessment for diagnosed endocrine disorders was performed.

    • Main Results:

    • 3 out of 31 MS patients (9.7%) presented with diagnosed endocrine diseases: primary hypothyroidism, primary amenorrhea, and primary male hypogonadism.
    • No patients were diagnosed with endocrine diseases of the hypothalamus, pituitary, or adrenal glands.
    • Impaired post-stimulatory secretion of cortisol, growth hormone, or thyroid-stimulating hormone was observed in 7 out of 31 patients (22.6%).

    Conclusions:

    • Overt endocrine diseases are uncommon in MS patients, but not absent.
    • A significant subset of MS patients may have subclinical or preclinical endocrine insufficiency.
    • Further monitoring of endocrine function in MS patients is warranted to detect and manage potential deficiencies.